• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.

作者信息

Vergin H, Ferber H, Zimmermann I, Neurath G B

出版信息

Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):350-7.

PMID:6975762
Abstract

In patients with chronic obstructive airway disease, the elimination half-lives of tetroxoprim (TXP) and sulfadiazine (SDZ) were found to be 8.6-9.0 h and 7.9-8.5 h, respectively, after administration of a single dose. The corresponding values for trimethoprim (TMP) and sulfamethoxazole (SMZ) were found to be 13.7 and 15.7 h, respectively. In the case of therapeutic multiple dosing, TMP and SMZ accumulate in patients' serum (tau = 12 h). Over a 10-day period of investigation, the serum levels measured were used to calculate half-life values of 12.9 h for TMP and 10.7 h for SMZ. Under the conditions of steady state, half-lives of 5.0 and 5.6 h were calculated for TXP and SDZ, respectively, which in the case of TXP might be explained kinetically. Due to the parallel change in the elimination-rate constants, no accumulation of TXP and SDZ in patients' serum (tau = 12 h) can occur.

摘要

相似文献

1
Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.
Int J Clin Pharmacol Ther Toxicol. 1981 Aug;19(8):350-7.
2
Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients.老年患者中复方新诺明和复方四嗪的药代动力学
Infection. 1981;9(5):239-43. doi: 10.1007/BF01640724.
3
Pharmacokinetics of co-trimazine after single and multiple doses.单次及多次给药后复方磺胺甲恶唑的药代动力学
Arzneimittelforschung. 1987 Jan;37(1):70-4.
4
Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers.四种不同磺胺类药物与甲氧苄啶联用在人类志愿者中的比较药代动力学研究。
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):23-5.
5
Trimethoprim-sulfadiazine in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration.马匹使用甲氧苄啶-磺胺嘧啶:单剂量静脉给药后的血清、滑膜、腹膜和尿液浓度
Am J Vet Res. 1983 Apr;44(4):540-3.
6
[Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].[肝病患者与健康人联用甲氧苄啶和磺胺甲恶唑的药代动力学比较]
Arzneimittelforschung. 1975 Apr;25(4):656-66.
7
Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
Clin Nephrol. 1984 Nov;22(5):239-43.
8
Steady-state pharmacokinetics of sulfamethoxazole and trimethorprim in man after rectal application.
Arzneimittelforschung. 1979;29(2):345-9.
9
Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.甲氧苄啶-磺胺甲恶唑在母马体内的药代动力学、体液及子宫内膜浓度
Am J Vet Res. 1988 Jun;49(6):918-22.
10
[Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
Fortschr Med. 1984 Mar 8;102(9):244-6.

引用本文的文献

1
Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.齐多夫定、甲氧苄啶和氨苯砜在人类免疫缺陷病毒感染患者中的药代动力学相互作用。
Antimicrob Agents Chemother. 1996 May;40(5):1231-6. doi: 10.1128/AAC.40.5.1231.
2
The pharmacokinetics of tetroxoprim in the dog.四氧普明在犬体内的药代动力学。
Eur J Drug Metab Pharmacokinet. 1982;7(3):197-202. doi: 10.1007/BF03189566.
3
Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.抗菌化疗中酶抑制剂的临床药代动力学
Clin Pharmacokinet. 1988 Sep;15(3):133-64. doi: 10.2165/00003088-198815030-00001.